-
Latest News
- Specifics of CFS coping strategies identified in a French flash survey during the COVID-19 containment
- Insights into metabolite diagnostic biomarkers for ME/CFS
- WAMES is growing to meet the challenges of 2021
- New study shows reduced ability to regulation of the cardiovascular system in patients with ME/CFS
- Dissecting the nature of Post-Exertional Malaise
Archives
Tag Archives: Kine Alme
Intravenous cyclophosphamide in ME/CFS. An open-label phase II study
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study by Ingrid G Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J Tronstad, Kristin Risa, Kine Alme, Marte K Viken, Benedicte A Lie, Olav … Continue reading
Posted in News
Tagged Alexander Fosså, Asgeir Lande, Benedicte A Lie, cancer, chemotherapy, CycloME study, Cyclophosphamide, Ingrid G Rekeland, Irini Ktoridou-Valen, Kari Sorland, Karl J Tronstad, Kine Alme, Kristin Risa, Mari Holsen, Marte K Viken, Olav Dahl, Øystein Fluge, Prof Olav Mella
Comments Off on Intravenous cyclophosphamide in ME/CFS. An open-label phase II study
